SCHEMBL28560342

SCHEMBL28560342

COc1cc(N)c(C(N)=O)cc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
TDP1 Q9NUW8 5/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 2/20 0.46
LMNA P02545 2/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 3/20 0.45
MAPT P10636 1/20 0.44
GRIN2D O15399 2/20 0.43
GRIN3B O60391 2/20 0.43
GRIN1 Q05586 2/20 0.43
GRIN2A Q12879 2/20 0.43
GRIN2B Q13224 2/20 0.43
GRIN2C Q14957 2/20 0.43
GRIN3A Q8TCU5 2/20 0.43
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3832008 0.94 TDP1 (0.46) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL27783200 0.88 PKM (0.50) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL6112750 0.84 MAPT (0.47) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL6815706 0.84 POLB (0.49) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL15486469 0.83 TDP1 (0.45) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL3654416 0.83 LMNA (0.52) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL11555366 0.81 HTT (0.55) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL6375580 0.81 HTT (0.55) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL4639621 0.81 MAPT (0.47) ALDH1A1TDP1KDM4EPOLBLMNA
SCHEMBL3829979 0.81 PKM (0.54) ALDH1A1TDP1KDM4EPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112707845-B Preparation method of dacatinib intermediate 成都伊诺达博医药科技有限公司 2023-04-28 CN disclosed
CN-112707846-B Preparation method of dacatinib key intermediate 成都伊诺达博医药科技有限公司 2023-04-21 CN disclosed
CN-112707846-A Preparation method of dacomitinib key intermediate 成都伊诺达博医药科技有限公司 2021-04-27 CN disclosed
CN-112707845-A Preparation method of dacomitinib intermediate 成都伊诺达博医药科技有限公司 2021-04-27 CN disclosed